Tacalyx extends seed funding round to raise over €14m

Cancer-focused biotech Tacalyx has extended its seed financing round to raise over €14m ($15.03m).

Jun 12, 2024 - 04:00

Tacalyx extends seed funding round to raise over €14m

Cancer-focused biotech Tacalyx has extended its seed financing round to raise over €14m ($15.03m).

Read the original article

Tags:

Previous Article

AstraZeneca champions early kidney disease diagnosis with modelling data

UK clinical trial sector must address prolonged timelines, say experts

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

NVIDIA invests $50m in AI-enabled drug discovery

NVIDIA invests $50m in AI-enabled drug discovery

Jul 13, 2023

HPV vaccines are so effective that new screening policies may be in order, suggests study

HPV vaccines are so effective that new screening polici...

Nov 9, 2023

Fresenius Kabi wins FDA approval for Stelara biosimilar Otulfi

Fresenius Kabi wins FDA approval for Stelara biosimilar...

Oct 2, 2024